Search clinical trials for: PCR multiplex

Total 8192 results

Assiut University

Not yet recruiting

Detection of Krupple Like Factor -1(KLF1/ EKLF) DNA Mutations in Beta Thalassemia Patients

EKLF Mutations in Beta Thalassemia Patients
Central Hospital, Nancy, France

Not yet recruiting

Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic (VirCoV+)

Viral Pneumonia

France
Oslo University Hospital

Recruiting

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

Metastatic Colorectal Cancer | Cholangiocarcinoma | Pancreas Adenocarcinoma

Norway
Assiut University

Not yet recruiting

Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.

Community-acquired Pneumonia
Assiut University

Not yet recruiting

Role of Multiplex PCR in CAP

Community-acquired Pneumonia
Fondazione Policlinico Universitario Agostino Gemelli...
Catholic University of the Sacred Heart

Recruiting

HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array (LIGHTNING)

VAP - Ventilator Associated Pneumonia | HAP - Hospital Acquired Pneumonia

Italy
AusDiagnostics Pty Ltd.

Not yet recruiting

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Respiratory Viral Infection
CHU de Reims

Recruiting

Use of a New Method for the Microbiological Diagnosis of Severe Corneal Infection (ABCORFILM)

Infectious Keratitis | Microbial Keratitis | Corneal Infection

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Evaluation of a New Multiplex Quantitative PCR Technique for the Diagnosis of Echinococcosis (HIS-QPCR-ECH)

Diagnosis | Echinococcosis

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

GastroIntestinal Panel in Kidney Transplant Patients (GIPIK)

Kidney Transplant; Complications | Diarrhoea;Acute | Diarrhea Infectious
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Complex Ocular Infection, Optimization of Microbiological Diagnosis (ICODIA)

Keratitis | Endophthalmitis

France
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Melanoma | Sarcoma | Acute Myeloid Leukemia | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Stage III Pancreatic... and other conditions

United States
Assistance Publique - Hôpitaux de Paris
BioMérieux

Recruiting

Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial (MULTI-EXA)

Acute Exacerbation of COPD

France
Huashan Hospital

Recruiting

Early Identification and Severity Prediction of Acute Respiratory Infectious Disease (ESAR)

Acute Respiratory Infection | Severe Pneumonia | Next Generation Sequencing | Multiplex PCR

China
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell Myeloma

United States
National Cancer Institute (NCI)

Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

Malignant Solid Neoplasm | Acute Myeloid Leukemia | Multiple Myeloma | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer... and other conditions

United States, Puerto Rico
SWOG Cancer Research Network
National Cancer Institute (NCI); Janssen, LP

Recruiting

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)

Multiple Myeloma

United States, Canada
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma

United States
University of Colorado, Denver
BioFire Diagnostics, LLC

Completed

Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala

Sepsis | Bacteremia

Guatemala
Hisar Intercontinental Hospital

Completed

Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases (PCR)

Multiplex Respiratory PCR Results in Diabetic Pneumonia Cases

Turkey
National Cancer Institute (NCI)

Active, not recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast Carcinoma

United States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple Myeloma

United States, Saudi Arabia, Puerto Rico
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous Adenocarcinoma

United States, United Kingdom
National Cancer Institute (NCI)
NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaborators

Active, not recruiting

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) (TAILORx)

Hormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast Adenocarcinoma

United States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Recurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7

United States
National Cancer Institute (NCI)

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditions

United States, Puerto Rico, Guam
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Smoldering Multiple Myeloma | Light Chain Deposition Disease

United States, Puerto Rico, Ireland
Assistance Publique - Hôpitaux de Paris
QIAGEN Gaithersburg, Inc

Active, not recruiting

Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room (PROMCAP)

Community-acquired Pneumonia

France
Incheon St.Mary's Hospital

Withdrawn

Optimal Tailored Treatment for H. Pylori Infection

Helicobacter Pylori Infection | Antibiotic Resistant Infection

Korea, Republic of
Centre Hospitalier Henri Duffaut - Avignon
Institut de Formation en Ostéopathie du Grand Avignon

Terminated

Heart Rate Variability, Vagus Nerve and Cancer

Multiple Myeloma | Colorectal Cancer | Lung Cancer | Non Hodgkin Lymphoma

France
OHSU Knight Cancer Institute
Oregon Health and Science University

Terminated

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Primary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditions

United States
Avicenna Military Hospital

Completed

Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.

Hospital-acquired Pneumonia | Ventilator Associated Pneumonia | Community-acquired Pneumonia

Morocco
University of Calgary
BioMérieux

Completed

Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia

Diarrhea Bloody

Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene Corporation

Active, not recruiting

Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma

Multiple Myeloma in Relapse

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Plasma Cell Myeloma

United States, Puerto Rico
Pathnostics

Withdrawn

Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection

Urinary Tract Infections

United States
Instituto Mexicano del Seguro Social

Completed

Effect of the Use of Probiotic S. Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR.

Viral Diarrhea

Mexico
University of California, San Francisco

Completed

A Study of Oxidative Pathways in MS Fatigue

Progressive Multiple Sclerosis | Fatigue

United States
Assistance Publique - Hôpitaux de Paris

Completed

Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome. (Antibio_STA)

Sickle Cell Disease | Acute Chest Syndrome

France
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Assiut University

Completed

Detection of Bloodstream Pathogens in Hematological Malignancies

Bloodstream Infection

Egypt
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); The Leukemia and Lymphoma Society

Completed

Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma

Chronic Lymphocytic Leukemia | Plasma Cell Myeloma

United States
Hospital Universitari de Bellvitge
Fundació La Marató de TV3; Department of Health, Generalitat de Catalunya

Terminated

Impact of Comprehensive Molecular Tests on Antimicrobial Stewardship in Community-acquired Pneumonia (RADICAP)

Community-acquired Pneumonia

Spain
DR. MALA KHAN

Completed

Efficacy of a Multiplex BangasureTM RT-PCR Kit for the Detection of COVID-19 (COVID-19)

COVID-19

Bangladesh
Chinese University of Hong Kong
Prince of Wales Hospital, Shatin, Hong Kong

Completed

Multiplex PCR -Microarray-based Assay in the Detection of Mycobacterium

Tuberculosis | Non-Tuberculous Mycobacterial Pneumonia

Hong Kong
Assistance Publique - Hôpitaux de Paris

Completed

RAPid SOlution for Diagnosis of Respiratory Infection in Pediatric Intensive Care Unit (RAPSODI)

Severe Infections Pneumonia With Invasive Ventilation in PICU

France
Assistance Publique - Hôpitaux de Paris
Biofire

Completed

Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ER (PRODIARRAY)

Acute Diarrhea | Acute Colitis of Presumed Infectious Origin

France
University Hospital, Grenoble
GenMark Diagnostics

Completed

Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia. (HEMOFAST)

Fungemia | Bacteremia Sepsis

France
Assistance Publique - Hôpitaux de Paris
BioMérieux

Completed

Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia (MultiCov)

Pneumonia | Covid19

France

Search clinical trials for: PCR multiplex

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations